Navigation Links
Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427
Date:7/28/2014

CHAPEL HILL, N.C., July 28, 2014 /PRNewswire/ -- Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers. The company has now initiated dosing of hospitalized patients with decompensated heart failure in a Phase IIa clinical trial designed to further evaluate the drug's safety and tolerability as well as its dosing levels.

The Phase I clinical trial evaluated the safety and tolerability of 24- and 48-hour continuous intravenous infusions of CXL-1427 in 80 healthy volunteers. The trial's results showed not only that CXL-1427 was well tolerated with limited adverse events, but also that it is clearly hemodynamically active. Cardioxyl's ongoing Phase IIa study is a randomized, double-blinded, placebo-controlled, invasive hemodynamic study designed to evaluate the safety, tolerability and hemodynamic effects of 6-hour intravenous infusions of CXL-1427 in hospitalized patients with advanced heart failure. It is being conducted at up to 34 clinical sites globally and will enroll approximately 48 hospitalized patients.

"We are very encouraged by the results seen in the first clinical trial for CXL-1427," said ShiYin Foo, M.D., Ph.D., Cardioxyl's Chief Medical Officer, "and we are excited to have begun our next stage of clinical testing in advanced heart failure patients. Heart failure patients have few effective options, and the pre-clinical and clinical data for CXL-1427 suggest that this could be an important new therapy for patients with ADHF."  

Nitroxyl, the chemical name for HNO, has been studied for its potential as a treatment for heart failure. HNO dilates blood vessels and acts directly on the heart through a unique mechanism to
'/>"/>

SOURCE Cardioxyl Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cardioxyl Pharmaceuticals Raises $28 Million In Series B Financing Led By OrbiMed Advisors
2. Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
3. New Findings Published In Circulation: Heart Failure Show Potential Utility Of Cardioxyls HNO Donors As Novel Treatments For Heart Failure
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
8. Icahn Issues Statement Regarding Amylin Pharmaceuticals
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... October 24, 2014 Research ... addition of the "Global and Chinese Hemodialysis ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. ...
(Date:10/25/2014)... , October 24, 2014 ... http://www.researchandmarkets.com/research/wdq92g/global_and ) has announced the addition of ... Report 2014"  report to their offering.  ... Global and Chinese Acne Medication Industry Report ... on the current state of the global ...
(Date:10/22/2014)... SANTA CLARA, Calif. , Oct. 22, 2014 /PRNewswire/ ... today announced the introduction of the cQUB™-1 (cQuest Ultrasound ... cQUB white-label ultrasound systems designed and manufactured by Cephasonics ... brand name and model number. Cephasonics will be showcasing ... 2014 being held this week in Chongqing, ...
Breaking Medicine Technology:Global and Chinese Hemodialysis Concentrates Industry Report 2014 2Global and Chinese Hemodialysis Concentrates Industry Report 2014 3Global and Chinese Acne Medication Industry Report 2014 2Global and Chinese Acne Medication Industry Report 2014 3Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3
(Date:10/25/2014)... October 25, 2014 The proposed consolidation ... be addressed in December, when the U.S. Judicial Panel ... According to a Hearing Session Order issued by the ... will be heard on December 4, 2014, in Charleston, ... a.m. (In Re: Xarelto Products Liability Litigation, No. 2592) ...
(Date:10/25/2014)... (HealthDay News) -- Arriving home safe and sound is one ... end, be sure that costumes and goody bags have reflective ... an emergency medicine doctor at Meadowlands Hospital Medical Center in ... and costumes should be flame-resistant, Davis said. He offers ... makeup, test it on a small area of skin first ...
(Date:10/25/2014)... Background: , In 1998 Bob Savage ... a pioneer in the field of establishing recovery community organizations. ... system and when he retired, he set out to answer ... service. , 1. Where are the people ... , 2. Can the recovery community be organized to ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 ... firm which verifies IT-accessibility for disabled users by ... Approved® logo to Mackin Educational Resources of ... resource management system and to the Minnesota Alliance ... "Own Best Medicine" website. Both ...
(Date:10/25/2014)... 25, 2014 QueenBeeTickets.com has a variety ... selection at affordable prices. Bob Seger & The Silver ... and Nationwide Arena are going on sale October 25 ... Here to browse the selection of tickets for ... , The famous singer is touring North America beginning ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:Tips for Safe Trick-or-Treating 2Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2
... initiation of a high profile, high-tech - and ?6.2billion computer ... 50 million patients//. Today however this grand scheme is ... first set grandiose plans, by 2005, X-rays lab reports and ... would be followed by prescriptions that would be flashed electronically ...
... polio attack. ,Since last 10 years this counted ... Wild Type was been proved to be responsible – preliminary ... ,Dr Kalumbi Shangula - permanent secretary said: Children below 5 ... admitted to hospitals in Windhoek. ,The National ...
... a leaf out of China to address regulatory and infrastructure ... a global leader // , even as the sector is ... to become a regional hub for R&D, manufacturing and exports ... said. ,'India needs to look to the achievements of ...
... V S Gaitonde and Jehangir Sabavala displayed their work ... paintings and sculptures held at Durban for a period ... having a cultural co-operation between Indian and South African ... like Iziko South African National Gallery (Iziko Sang) and ...
... in the coming five years are estimated to exceed 300 ... Wednesday//. ,At a conference of the Chinese Academy of ... diseases) and AIDS prevention centre under the ministry of health, ... China are estimated to reach 285.57 billion yuan ($35.6 billion) ...
... to open its 100-bed super-specialty hospital in Oman by the ... of Oman newspaper quoted Apollo Medical Centre (AMC) managing director ... first of its kind in the private sector in Oman. ... between super-specialty hospitals and polyclinics in the Gulf nation. ...
Cached Medicine News:Health News:NHS Billions Spent on High Cost Computer Scheme 2
Aire-Cuf® tracheostomy tubes are ideal for short-term to medium-term ventilator support....
... flange tracheostomy tubes are intended ... proper length fixed neck flange ... ,Adjustable neck flange Hyperflex™ ... for both horizontal and vertical ...
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions....
KIMBERLY-CLARK BALLARD Neonatal and Pediatric TRACH CARE Y features lavage/irrigation port and locking thumb port. Multiple French sizes and packaging configurations. Gamma sterilized....
Medicine Products: